U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07006506) titled 'A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant' on May 22.
Brief Summary: The purpose of this study is to find out whether adding belumosudil to a usual approach for reducing the risk of graft-versus-host disease (GVHD) may be an effective GVHD prevention approach for people with blood cancer who have a stem cell transplant. The investigators will also look at the safety of the study approach.
Study Start Date: May 21
Study Type: INTERVENTIONAL
Condition:
Graft Versus Host Disease
Graft Vs Host Disease
Hematologic Malignancy
Intervention:
DRUG: Belumosudil
Belumosu...